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ABSTRACT
Highly Integrated and Miniaturized 3D Printed Serial Dilution Microfluidic Devices for
Dose-Response Assays
Jose Luis Sanchez Noriega
Department of Electrical and Computer Engineering, BYU
Master of Science
The ability to generate a range of concentrations of various solutions rapidly and conveniently is an ongoing need in biotechnology. In this thesis we demonstrate how we took advantage
of the full process control afforded by our recent custom high resolution 3D printer and resin
advances to realize highly integrated and miniaturized microfluidic components for simultaneous
on-chip serial dilution for dose-response assays. With judicious selection of mixed layer thicknesses and pixel-by-pixel dose control, we show that the diameter of 3D printed membrane valves
can be reduced from 300 µm to 46 µm. We further introduce an entirely new kind of 3D printed
valve, termed a squeeze valve, in which the active area is reduced still further to 15 µm × 15 µm.
We demonstrate and characterize pumps based on each type of valve and introduce a short (<1 mm
long) high aspect ratio channel that enables rapid diffusion-based mixing. We show that combining
two pumps with this diffusion mixing channel results in a highly compact 1:1 mixer component.
Connecting 10 of these components in series yields a miniature 10 stage 2-fold microfluidic serial
dilution module that from two solution inputs simultaneously generates 10 output concentrations
that cover three orders of magnitude. We show the efficacy of our serial dilution approach by
demonstrating an assay for dose-dependent permeabilization of A549 cells in different concentrations of digitonin integrated into a single device. Our demonstration of component miniaturization
in conjunction with a high degree of integration illustrates the promise of 3D printing to enable
highly functional and compact microfluidic devices for a variety of biomolecular applications.

Keywords: microfluidics, 3D printing, serial dilution, dose-response assays
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CHAPTER 1.

INTRODUCTION

An important need in biomedical and pharmacological assays is to have a way of diluting
certain drug into a relatively big span of concentrations in order to study how certain organisms
respond to this chemical in different doses. While this procedure can be performed manually, it is
prone to human errors, furthermore, the chemicals used are often not only limited, but expensive,
which makes this solution not very attractive. As a result of that, in pursuit of automating this
process, microfluidics stands up like the natural choice. The advantages of inexpensive device
contruction and small volume manipulation it provides are especially appealing for integrating
serial dilution and dose-response assays into individual integrated devices.
3D printing has shown, in recent years, to be a technology that not only simplifies the
process of fabricating microfluidic chips, but also allows to create sophisticated 3D structures
that would be much more complicated and expensive using more classical technologies. In the
past years, the focus of the research group I belong to has been to develop custom 3D printers
particularly suitable for fabricating microfluidic devices. The chips we have 3D printed contained
features ranging from passive components like channels, and splitters to active components like
valves, pumps, and mixers. Building upon those components and as a solution for the described
problem we designed a serial dilution mixer capable of diluting and pumping simultaneously an
input solution in concentrations that span three orders of magnitude.
In the following chapters, after presenting the research background, I start by demonstrating the further miniaturization of 3D printed membrane valves which are the building blocks of the
serial dilution mixer, then, I introduce a new, few-picoliter dead volume 3D printed valve, which
we call a squeeze valve, the valves are then combined to make pumps, and multiple pumps and
valves are integrated to make a simple, but effective diffusion-driven, compact, passive 1:1 mixer.
Finally, ten of these mixers are sequentially connected to create a serial dilution mixer with ten different outputs having relative concentrations that span three orders of magnitude as stated before.

1

The utility of our on-chip serial dilution system is illustrated by demonstrating the dose-dependent
permeabilization of A549 cells in different concentrations of digitonin. This initial result highlights the broad potential applicability of our 3D printed microfluidic serial diluter, for example
in drug-screening, personalized medicine, or other experimental applications. The final chapter
summarizes the results and gives some direction and ideas into what research I think should be
pursued next.

2

CHAPTER 2.

BACKGROUND

Microfluidics refers to the field of study for controlling and manipulating fluids that are constrained to micro-scale dimensions. Even though fabricating microfluidic devices imposes certain
challenges principally due to the precision required for making chips with such small dimensions,
the ability it provides to integrate and automate different biomedical assays in a single chip, plus
the small reagent volumes required for performing those assays [3] are only some of the advantages
that makes it attractive for different biochemical applications.
Microfluidic chips are often fabricated using an elastomeric polymer called polydimethylsiloxane (PDMS). Using this material, however, requires the use of a cleanroom and several steps
to build and bond each of the layers that compose the whole device, which makes it not very
appealing in terms of start-up cost and time (up to days) for rapid-prototyping of microfluidic
devices [1].
3D printing has emerged in the past years as an alternative that provides a way of building microfluidic devices prototypes for proof-of-principle demonstration in a much more time
convenient way while also removing the need of setting up a cleanroom and the costs that this involves [1]. Stereolithography 3D printing, in particular, consists on building a chip layer by layer
by projecting an image with a particular light spectrum with patterns that selectively polymerizes
regions of a photopolymerizable resin. This allows to build chips with integrated channels and
other more complex 3D structures in even less than hour.
Our research group has been involved since 2013 in developing tools and techniques that
could facilitate the fabrication of 3D printed microfluidic devices with different integrated features
and for different applications. In the following paragraphs I summarize the main published papers
that reflect that work, which finally led to the research we present in this thesis.
In 2015, Rogers et al. [1] reported the fabrication of horizontal microfluidic channels with
cross sectional dimensions as small as 250 µm (tall) × 350 µm (wide) 3D printed using a commer-
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Figure 2.1: Chip with two 3D printed valves of different sizes. Published in 2015. [1]

cial 3D printer (B9 Creator v1.1) and a custom resin formulation prepared by mixing 1% (w/w)
Irgacure and 0.2% (w/w) Sudan I in Polyethylene glycol diacrylate (PEGDA). Additionally, they
reported the fabrication of the first 3D printed valves (see Fig. 2.1) in a microfluidic system with
diameters as small as 2 mm that could be actuated successfully up to 800 times.
The same year, Hua Gong et al. [4] addressed the problem that commercial resins were
more suitable for 3D printing external features, but not microvoid features which essentially form
most microfluidic components. They used an optical approach to lay the mathematical foundations to formulate resins that could minimize the cross sectional dimensions of a flow channel and
internal void features in general given certain properties of the resin and digital light processing
stereolithography 3D printer used. Using this approach they formulated and tested resins composed by 1% (w/w) Irgacure 819 and variable amounts of Sudan I (0.05%, 0.1%, 0.15%, 0.2%,
0.4% or 0.6% w/w) in PEGDA and were able to successfully 3D print a flow channel with cross
sectional dimensions as small as 60 µm × 108 µm using an Asiga Pico Plus 27 3D printer.
Taking advantage of the previous work, in 2016, Hua Gong et al. [5] reported the successful
fabrication of 3D printed valves that had only 1.08 mm in diameter, 10% of the volume of the
previously reported valves, and that could be actuated up to 1 million times. They combine three
of these valves to create a pump that could produce a flow rate as high as 40 µL min−1 , and 5
valves to create a 3-to-2 multiplexer.
In pursuit of creating smaller and smaller features that could allow to integrate more processes in a single microfluidic chip, Hua Gong et al. [2]. fabricated, and demonstrated in 2017,
4

Figure 2.2: 3D CAD model of the custom 3D printer published in 2017. [2]

a custom digital light processor stereolithographic (DLP-SLA) 3D printer (see Fig. 2.2) that had
an image plane resolution of only 7.6 µm (the previous one, Asiga Pico Plus 27 commercial 3D
printer, had a 27 µm pixel pitch) and used a 385 nm LED that allow them to have a greater range
of possibilities for formulating custom resins that were more appropriate for printing features with
smaller dimensions. Their final resin formulation was prepared by mixing 1% (w/w) Irgacure 819,
and 2% 2-nitrophenyl phenyl sulfide (NPS, w/w) in PEGDA which allow them to successfully
fabricate a microfluidic flow channel with cross section as small as 18 µm × 20 µm.
The increasing number of features that could be integrated in a single chip resulted in
a higher number of required fluid and pneumatic connections, this led to Hua Gong et al., in
2018 [6], to devise a method that allow them to separate the world-to-chip interconnections from
the microfluidic features in two different chips. They integrated microgaskets in one of the chips
which along with a clamping mechanism that compressed both chips together allowed them to
interconnect each of the fluid and pneumatic lines in both chips without any leaking when applying
pressures up to 50 psi. They tested the utility of this mechanism by actuating each of the rows of
a 9 x 5 array of membrane valves a minimum of 10,000 times successfully. Each of these valves
had a diameter of 300 µm, which were the smallest reported 3D printed valves at that time.
Finally, in 2019, Hua Gong et al published a paper in which they demonstrated different 3D
printed active microfluidic components tightly integrated into a single chip [7]. In particular, they
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introduced two types of selectable dilution mixer pumps, a linear dilution mixer pump (LDMP),
which they showed was able to dilute a fluid into one ratio of a linear set possibilities of (1/6,
2/6, ..., 5/6), and a parallelized dilution mixer pump (PDMP), which increased the dilution ratio
possibilities provided by the LDMP by increasing the number of pumps connected to each solution
that fed the mixer, which let them achieve a dilution ratio as low as 1/16.
We wanted to leverage the already proven mixing capabilities that we could achieve using
the 3D printed microfluidic chips we fabricated by automating dose-response assays.
Dose-response assays allow to characterize the response of certain organisms to a particular
stimulus. This stimulus, which for our case will correspond to a chemical solution, needs to be applied in different concentrations in order to generate a dose-response curve. These concentrations
are typically obtain by serially diluting the original input solution. Unfortunately, the microfluidic
dilution systems demonstrated to date have multiple disadvantages. Many require a relatively large
fluidic device footprint and associated volumes to accommodate many channels with appropriate
lengths to facilitate diffusional mixing. [8]–[11] Others have highly complex fluidic networks that
hinder broad application beyond engineering groups with access to sophisticated microfabrication
facilities. [12] Nearly all use PDMS as the device material with its inherent issue of non-specific
adsorption. The SlipChip approach for serial dilution [13] shows promise but requires manual operator actions for dilution and is limited to much smaller nanoliter volumes that are not broadly
applicable in multiple assay formats.
The next sections of this thesis will show how we address these limitations by using the
valves and pumps reported in the previous papers published by our group as building blocks to design and fabricate an individual 3D printed device that integrates a 10-stages passive serial dilution
mixer, whose outputs cocentrations span 3 different orders of magnitude.
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CHAPTER 3.

3.1

MINIATURIZATION OF VALVES AND PUMPS

Extreme miniaturization of 3D printed valves
On-chip integrated valves are critical components to control fluid flow in microfluidic de-

vices and are an important element in the popularity of PDMS microfluidics in which it is straightforward to create valves based on the elastomeric nature of PDMS [14]. There has been strong
motivation to endow 3D printed microfluidics with a similar valve fabrication capability. The first
demonstration of 3D printed valves was shown in 2015 by our group [1], closely followed by the
Folch group [15]. In both cases the valves were not particularly small, 2 and 3 mm diameter for
the former and 10 mm for the latter. Since then, there has been a continual drive to reduce the size
of 3D printed valves. In 2016 we reported 1.08 mm diameter valves using a commercial 3D printer
and custom resin [5]. With the advent of our first custom 3D printer and associated resin [2], we
showed in 2018 the realization of 300 µm diameter valves [6]. In 2019 Folch et al. demonstrated
500 µm diameter valves using a commercial 3D printer and a custom resin [16]. In this paper
we use an improved custom 3D printer and control software to demonstrate 3D printed membrane
valves as small as 46 µm in diameter. We also introduce a new type of valve, which we call a
squeeze valve, that lets us create even smaller valves down to ∼15µm×15µm.

3.1.1

Membrane valves
A membrane valve, as shown in Fig. 3.1(a-c), is composed of a control (pneumatic) cham-

ber and fluid chamber separated by a thin membrane [1], [5], [6]. When the control chamber is
pressurized, the membrane deflects until it covers the channel connected to the center of the bottom
of the fluid chamber, blocking fluid flow and therefore closing the valve (Fig. 3.1(c)). When the
pneumatic pressure is released, the stretched membrane returns to its original position (Fig. 3.1(b)),
opening the valve. The control chamber is connected to two channels, one of which goes to an ex-
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Figure 3.1: 3D printed (a-o) membrane valves and (p-z) squeeze valves. (a) Schematic diagram
of membrane valve geometry with cut-away schematics showing a membrane valve in (b) open
and (c) closed states depending on pneumatic pressure applied through the control channel. (d-o)
Side- and top-view microscope images of (d-g) 20 pixel, (h-k) 12 pixel, and (l-o) 6 pixel diameter
valves in their open and closed states. (p) Schematic diagram of squeeze valve geometry with cross
section diagrams (rotated 90◦ ) showing a squeeze valve in (q) open and (r) closed states depending
on pneumatic pressure applied through the control channel, which squeezes together to close the
flow channel. (s-z) Microscope images of (s-v) 4×4 pixel (side- and top-view), (w,x) 3×3 pixel
(top-view), and (y,z) 2×2 pixel (top-view) valves in their open and closed states. All scale bars are
100 µm.

ternal pressure source, while the other is used to facilitate flushing unpolymerized resin left inside
after the printing process. This second channel is blocked before device use [6] so that there is
only one pneumatic connection to a given control chamber during operation.
A critical limiting factor when miniaturizing 3D printed valves is the 3D printer x-y resolution. Our 3D printer has a 7.6 µm pixel pitch such that all microfluidic features are defined by
projected images comprised of 7.6 µm square pixels. [2] One consequence is that as the diameter of the cylindrical valve region is reduced to relatively few pixels, the edges of the nominally
circular membrane become more pixelated.
8

Table 3.1: Membrane valve parameters and closing pressures. All dimensions in microns unless
otherwise noted. Symbols refer to Fig. 3.2(a).

Diameter
(pixels)
20
12
6

Diameter
(D)
152
91
46

Membrane
layer
thickness
(t)
7
4
4

Fluid
chamber
height
(h)
24
20
18

Center
channel
width
(w)
46
30
15

Center
channel
height
(s)
50
30
10

Edge
channel
vertical
overlap
(ov )
12
10
10

Edge
channel
horizontal
overlap
(oh )
15
8
0

Exposure
Time
(ms)
380
280
200

Figure 3.1(d-o) shows side and bottom views of 3D printed membrane valves with diameters ranging from 20 pixels (152 µm) down to six pixels (46 µm) under open and closed conditions.
In all cases, the valves function as designed to block or allow fluid flow depending on whether the
control chamber is pressurized or not. Careful comparison of the cross-section micrographs, (d,f),
(h,j), and (l,n), show clear deflection of each membrane when the control chamber is pressurized
to close the valve. In particular, note in Fig. 3.1(n) compared to Fig. 3.1(l) the remarkable amount
of deflection exhibited by the thin 6-pixel diameter valve membrane.
A critical capability of the custom 3D printers we have built [17] is the ability to change
the layer thickness on a layer-by-layer basis, along with the optical dose of each layer, to create
polymerized features optimized for their designed function. For example, Fig. 3.2(a) and Table 3.1
specify the design dimension parameters used for creating the different size membrane valves.
Note in particular the different layer thicknesses and exposure times for the membrane layer, which
in the case of the 6-pixel diameter valves is designed to be 4 µm.
The pressure required to close a membrane valve is determined by the membrane’s area
(πD2 /4), the fluid chamber height (h), the cross-section area (w2 ) of the channel to be blocked,
and the membrane thickness. The latter is ultimately defined by the optical dose the membrane
receives, since there is unpolymerized resin in the region behind the membrane that polymerizes
as the dose increases. [2], [4] The dose is proportional to the time the membrane is exposed by
the 3D printer light source. For the fabrication parameters given, Table 3.1 shows the measured
minimum pressure required to fully close the valves: as small as only 9 psi for the 6 pixel valve.
Figures 3.2(b-d) show cross sectional views of each of the membrane valves. The vertical
grid lines delineate the boundaries of 7.6 µm pixels, while the horizontal grid lines indicate the
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Closing
Pressure
(psi)
25
14
9

Figure 3.2: (a) Membrane valve designed dimension parameters, (b-d) membrane valve exposure
times. (e) Squeeze valve designed dimension parameters, (f-h) squeeze valve exposure times.
Tables 3.1 and 3.2 specify the variable layer thicknesses used for each type of valve.
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build layers, which are mostly designed to be 10 µm in thickness, except for the membrane and
fluid chamber layers. As seen in the figures, the optical dose that each of the non-void pixels
receives is not uniform within a layer. This mainly has to do with the fact that the void features
can end up polymerized if the regions on top of or next to them are overexposed. [2], [4] Having
complete control over our custom 3D printer allows us to apply multiple independent exposure
images, each with their own exposure time, to a single layer in order to control the dose on a
pixel-by-pixel basis. This permits us to not overexpose on top of or next to void features, while
maintaining bulk chip strength by applying a higher optical dose to bulk regions.
Numerous trade-offs go into determining specific choices for exposure times and layer
thicknesses in the broad design parameter space available for a given valve size. For example, we
can reduce the actuation pressure for 20-pixel valves to below 15 psi if we decrease the membrane
thickness and fluid chamber height. However, this can make the membranes too weak for chips
in which we have many concentrated void features (due to the printing process) and lower their
response time, which we require to be fast (≤15 ms) if we want to use them as part of pumps,
which we show in the next section.
The pumps and mixers based on membrane valves that we use for serial dilution devices
use 20-pixel valves, since the 12 and 6 pixel valves were investigated after we had already tested
the pumps and mixers.
Lastly, we show in Fig. 3.3 a vertically oriented 3D printed membrane valve, in which its
membrane is comprised of 30 successively 3D printed stacked layers to create a 300 µm diameter
membrane, which is equivalent to the size of the horizontal 40-pixel diameter valves we reported in
Ref. [6]. This demonstrates the geometric versatility of the microfuidic designs that our 3D printer
is able to create.
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Figure 3.3: Vertically oriented membrane valve. (a) Schematic, oblique view. (b-c) Microscope
top-view photos under (b) open, and (c) closed (15 psi) states.

3.1.2

Squeeze valves
The geometry of our newly invented squeeze valve is shown in Figs. 3.1(p-r). As illus-

trated in Fig. 3.1(p), the height of the fluid channel is significantly reduced as it passes through a
vertically split control channel. The top and bottom of the fluid channel are separated from each
control channel by a thin layer of polymerized resin. The resin layer thickness and exposure time
used to fabricate these small membranes are given in Table 3.2, and again leverages the fine independent control capabilities of our custom 3D printer. As shown in the microscope top view
images (Figs. 3.1(t)-(z)), the membranes have a square geometry that varies from 4×4 pixels (30
µm×30 µm) to 2×2 pixels (15 µm×15 µm). The membranes are defined by the widths of the
overlapping fluid and control channels, which are oriented at 90◦ with respect to each other. This
makes the region to be squeezed a cuboid with the top and bottom defined by square membranes.
When the control channel is pneumatically pressurized, the top and bottom thin membranes
deflect as illustrated in Fig. 3.1(r), closing the valve. When the control channel pressure is released,
the membranes snap back as illustrated in Fig. 3.1(q), thereby opening the valve. In Figs. 3.1(t)(z), the valve area appears red when a valve is open because of the aqueous red dye solution in the
fluid channel. When a valve is closed, there is no red color in the valve region because the red dye
solution has been squeezed out into the adjacent fluid channel.
As shown in Table 3.2, 2-pixel valves take as little as 12 psi to close. We were also able to
successfully 3D print and test 4-pixel squeeze valves with a single control channel (the top channel
in Fig. 3.1(p)). However, the pressure required to close these valves was over 60 psi. Hence,
12

Table 3.2: Squeeze valve parameters. All dimensions in microns unless otherwise noted. Symbols
refer to Fig. 3.2(e).
Width
(pixels)
4
3
2

Width
(w)
30
23
15

Separation
(s)
38
30
23

Membrane layer
thickness
(t)
10
10
7

Fluid channel
height
(h)
16
10
8

Exposure
Time (ms)
200
140
90

Closing
Pressure (psi)
38
26
12

Figure 3.4: 5-phase pumping cycle. In (i) both valves and DC are closed, whereas in (ii) V1 and
DC are open and V2 is closed. In (iii) V1 and V2 are closed and DC is open. In (iv) V1 remains
closed and DC and V2 are open. In (v) V1 and DC are closed and V2 is open. At this point the
pump sequence repeats, going back to (i).

splitting the control channel to pass both above and below the fluid channel is an effective strategy
to reduce the required actuation pressure.
Effectively fabricating such 3D geometries is enabled by our ability to independently specify layer thicknesses and pixel doses. Figure 3.2(e-h) shows a cross sectional view of each of the
squeeze valves and the exposure time applied to each of the pixels. Relevant geometric parameters are given in Table 3.2. Similar to the membrane valves in Fig. 3.2, we make extensive use
of the dose and layer thickness control capability of our custom 3D printer to finely control the
polymerization of the 3D printing process to achieve the desired device structures.

3.2

Characterization of 3D printed pumps
When an initially closed valve is opened, a certain volume of fluid is drawn from the at-

tached fluid channels into the enlarged fluid chamber volume created by movement of the valve
membrane. The opposite happens when an initially open valve is closed. We can use this fluid
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Figure 3.5: 3D printed pumps. (a,f,k) Schematic diagrams. (b,g,l) Side view microscope photos.
(c,h,m) Bottom view microscope photos. (d,i,n) Volumetric flow rate as a function of the pump
phase interval, (∆t). (e,j,o) Pump volume per cycle as a function of pump phase interval. All graphs
were obtained from testing at least 3 different pumps.
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Table 3.3: Pump timing logic. Red: valves closed; green: valves opened
t0
V1
DC
V2

t1

t2

t3

t4

• • • • •
• • • • •
• • • • •

displacement phenomenon to create a pump by connecting an additional valve to the fluid input
channel, and another to the fluid output channel, and appropriately synchronize opening and closing these valves in conjunction with the center valve to control which fluid channel the central
valve draws fluid from and which it expels fluid into. We previously showed that the 5-phase valve
opening and closing sequence summarized in Table 3.3 results in effective fluid pumping. [5] A
graphic illustration of the pump sequence is shown in Fig. 3.4 for a pump comprised of three 4pixel squeeze valves to pump fluid from an inlet valve (V1) to an outlet valve (V2). The squeeze
valves are in a closed state when the central part of the valve looks bigger and has the same color
as the horizontal (pneumatic control) lines, whereas it is in an open state when the central part
appears smaller and is the same color as the vertical (fluid) lines, which are filled with an aqueous
solution containing green food dye.
Since at any single phase of the pumping cycle either V1 or V2 is closed, the center valve
does not have to block fluid flow when it is actuated. As discussed in Ref. [5] for pumps based on
membrane valves, we therefore position both fluid channels at the edges of the fluid chamber so
that the structure can only displace fluid and not block fluid flow. We call this modified structure a
displacement chamber (DC). It defines the fluid volume pumped in each pump cycle. [7]
The first pump (Fig. 3.5(a-e)) is formed by two 20-pixel diameter membrane valves and a
20-pixel DC. The valve parameters are shown in the first row of Table 3.1. The DC has identical
parameters except its fluid chamber height is 31 µm instead of 24 µm to increase the amount of
fluid expelled during each pump cycle. Note that the increased fluid chamber height compared to
the valves is visible in the side view microscope photo in Fig. 3.5(b) (i.e., the height of the red fluid
chamber is larger for the DC). The measured pump flow rate is shown in Fig. 3.5(d) as a function
of the phase time, ∆t, which is defined as the time for a single phase in the 5-phase pump sequence
in Table 3.3. For example, a 50 ms phase time (250 ms pump cycle) results in a volumetric flow
rate of close to 0.1 µL/min.
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Data are shown in Fig. 3.5(d) for two cases relative to how a DC is opened, i.e., how the
membrane is transitioned from its deflected closed state to an open state. The ”no vacuum” case
refers to the control chamber being switched from positive pressure to atmospheric pressure such
that the main restoring force on the membrane is its mechanical relaxation from a stretched to an
unstretched condition. The ”with vacuum” case consists of switching from a positive pressure in
the control channel to a negative pressure, in which case there is an additional pneumatic restoring
force for the membrane. [5] As shown in Fig. 3.5(e), application of vacuum results in an approximately 30% higher volume expelled during each pump cycle, which is due to the negative pressure
in the control chamber causing the membrane to deflect up into the control chamber, thereby increasing the volume of fluid pulled into the fluid chamber. As an example, for a 50 ms phase time,
the fluid volume increases from approximately 0.3 nL to 0.4 nL.
The second pump (Fig. 3.5 (f-j)) is the same as the first except the diameter of the DC is
increased from 20 pixels to 40 pixels and the membrane is comprised of two 6 µm layers while the
fluid chamber height remains at 31 µm. The purpose of the increased DC diameter is to increase
the pump flow rate by increasing the volume expelled for each pump cycle. [7] We expect the
volume to be increased by a factor of 4 since the DC diameter is increased by a factor of 2 and the
fluid chamber height remains the same. The data shows that for a 50 ms phase time and the no
vacuum case, the pump volume per cycle increases as expected from 0.3 nL to 1.2 nL and the flow
rate increases from 0.075 µL/min to 0.3 µL/min.
The third pump (Fig. 3.5(k-o)) is formed by three 4-pixel squeeze valves. Note the extremely compact size of the pump: 182 µm × 167 µm × 136 µm = 0.0041 mm3 , which is achieved
in part by separating the valves by only 6 pixels (46 µm) along the flow channel. Commensurate
with its small size, its generated flow rate is also small. For example, Figs. 3.5(n) and 3.5(o) show
that for a phase time of 50 ms, the volumetric flow rate is approximately 8 nL/min, while the fluid
volume expelled during each pump cycle is 30 pL. To get a sense of scale for the generated volumetric flow rate, we can compare to the sweat generation rate for a human, which is 1 nL/min per
sweat gland, so the pump flow rate is equivalent to what is produced by 8 sweat glands. [18]

16

CHAPTER 4.

SERIAL DILUTION DEVICES

This chapter will demonstrate how we used the previously shown miniaturized valves and
pumps to create a 1:1 mixer by connecting two pumps to a high aspect ratio channel that favors
mixing by diffusion. Subsequently 10 of these mixers will be connected serially in order two
create a serial dilution mixer that spans 3 orders of magnitude. Finally, we will test the utility of
our serial diluter by performing a digitonin-based dose response assay that connects each of the 5
different-concentration outputs of a serial dilution mixer to a corresponding cell culture 3D printed
well.

4.1

Diffusion mixing
As is well-known, fluid mixing is a challenge at the low Reynolds numbers typical of mi-

crofluidic device operation since fluid flow is laminar. [19], [20] Over several decades, a wide variety of both passive and active mixing strategies have been demonstrated. Comprehensive reviews
of such strategies can be found in Refs. [19]–[21]. In this paper we take a different approach to
mixing that relies solely on one-dimensional (1D) diffusion in a narrow channel that is specifically
designed for fast mixing times (∼1 s) in a short length (<1 mm).
The time required to diffuse, tD , over a distance, l, is given by [22]

tD =

l2
2D

(4.1)

where D is the diffusion coefficient of the molecular species in the fluid that is to be mixed. Clearly,
the shorter the diffusion distance, l, the shorter the time it takes mix. For our mixer we therefore
choose to use a tall, high aspect ratio channel, as shown schematically in Fig. 4.1(a), in which
we load two fluids side-by-side such that the distance, l = w/2, over which molecules from one
fluid need to diffuse into the second fluid is small. If the dwell time of the fluids in the channel is
greater than tD , diffusion-based mixing will occur. For example, Fig. 4.1(b) shows diffusion time
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Figure 4.1: Diffusion mixing of (a) two thin sheets of fluid in a narrow vertical channel. (b)
Diffusion time for example molecules over a 15 µm diffusion length in an aqueous solution. Blue
= 30 kDa protein, Orange = fluorescein, Green = dissolved gas molecules. (c) SEM image of 3D
printed narrow diffusion mixing channel cross section.
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as a function of diffusion length for several representative diffusion coefficients. In the case of
fluorescein (orange curve), the needed dwell time is several hundred milliseconds if the diffusion
length is 15 µm. Figure 4.1(c) shows an SEM image of the cut cross section of a 4-pixel wide high
aspect ratio channel we designed for mixing given our 3D printer capabilities. Its average measured
width, w, is 30.9 µm, which results in a diffusion length of just over 15 µm, corresponding to
diffusion times ranging from 0.12 to 1.2 seconds for the diffusion coefficients shown in Fig. 4.1(b).
We are particularly interested in mixing two fluids in equal amounts to create a 1:1 mixture.
We can create a simple but effective 1:1 diffusion-driven mixer by connecting the outputs of two
identical pneumatically actuated pumps to the high aspect ratio diffusion channel such that the
fluids form adjacent sheets as schematically illustrated in Fig. 4.1(a). Figure 4.2(a-c) shows a 1:1
mixer based on two membrane valve-based pumps with 40-pixel DCs like in Fig. 3.5(f). Both
pumps have the same outlet valve in common [5], which is the inlet valve, Vin , to the diffusion
mixing channel. An extra valve, Vout , is added after the diffusion channel to ensure that the already
mixed fluid that has exited the diffusion channel does not interact with the fluids inside the channel
while they are still mixing. The diffusion channel is 950 µm long and 370 µm tall with tapered
entrance and exit heights. The total diffusion channel volume is 8.95 nL.
Table 4.1 shows the 9-phase timing sequence we use to operate the mixer. Fluid A is first
pulled into DCA , followed by fluid B into DCB , after which Vin and Vout are opened and fluid
from both DCs is simultaneously pushed into the diffusion channel, following which the process
repeats. For a 50 ms phase time, a single 9-phase mixer period is 450 ms. We deliberately designed
the volume of the diffusion channel to be nearly 4 times the volume pumped into it by both pumps
during a single 9-phase period such that the average fluid dwell time in the channel is nearly four 9phase mixer periods (i.e., 1.7 seconds). Note that this permits mixing even for proteins that are 10’s
of kDa. Mixing larger molecules with smaller diffusion coefficients can be performed in the same
mixer structure by increasing the dwell time in the diffusion channel. This can be accomplished by
decreasing the flow rate into the diffusion channel by increasing the phase time. Alternatively, the
diffusion channel dwell time can be increased by redesigning the 1:1 mixer module with a larger
volume diffusion channel having an increased height or length (or both), and/or by decreasing the
size of the pump DCs to reduce the effective flow rate into the diffusion channel for a given phase
time.
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Figure 4.2: (a-e) Single stage mixer using membrane valve-based pumps: schematic diagram (a)
perspective view and (b) top view, (c) microscope photo, (d) mixing test, and (e) time to equilibrium test. Note in (d) that the mean and standard deviation of the relative concentration are
both plotted on the left vertical axis. (f-h) Single stage mixer using squeeze valve-based pumps:
schematic diagram (f) perspective view and (g) top view, (h) microscope photo.
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Table 4.1: Timing sequence for membrane valve-based mixer. Red: valves closed; green: valves
open.
VA
DCA
VB
DCB
Vin
Vout

t0

t1

t2

t3

t4

t5

t6

t7

t8

•
•
•
•
•
•

•
•
•
•
•
•

•
•
•
•
•
•

•
•
•
•
•
•

•
•
•
•
•
•

•
•
•
•
•
•

•
•
•
•
•
•

•
•
•
•
•
•

•
•
•
•
•
•

Figure 4.2(c) shows a snapshot of the mixer while it mixes red and blue dyes to visually
illustrate mixing efficacy. To quantitatively measure mixer performance, we used fluorescence
measurements with a dilute fluorescein solution. We focused a microscope on the output channel region of interest (ROI) just to the right of the diffusion channel in Fig. 4.2(b) and acquired
fluorescence images of the fluorescent fluid, such that the obtained image intensity values were
proportional to the concentration of fluorescein inside the ROI.
A typical result is shown in Fig. 4.2(d) in which a measurement consists of first pumping
only the non-fluorescent fluid (fluid B) to obtain the minimum fluorescence intensity across the
ROI (0-15 seconds in Fig. 4.2(d)), followed by pumping only the fluorescein solution (fluid A) to
obtain the maximum fluorescence intensity (40-65 seconds). This is enabled by the fact that we
have separate control over each of the input pumps. Next, we pump both fluids using the previously
described 9-phase cycle to measure the fluorescence of the mixed fluids (90-120 seconds). At 120
seconds, we stop the pumps and close all valves. This allows us to monitor the standard deviation
of the mixed fluorescein concentration in the ROI as a function of time (120-140 seconds). As
described in Ref. [7], the evolution of the standard deviation over time is a measure of how well
mixed the fluid is, with a well-mixed fluid showing no change over time and a poorly mixed fluid
showing a decrease over time. Note that the standard deviation (orange curve in Fig. 4.2(d)) shows
no change in time, indicating that the fluorescein 1:1 dilution is well-mixed.
Finally, the time evolution of the mixed fluorescein concentration in the ROI is shown in
Fig. 4.2(e) for a starting state with no fluorescein in the 1:1 mixer module. As can be seen, it takes
approximately 20 seconds for the fluorescein concentration in the output channel to reach steady
state. Note that on the way towards steady state there is a periodic variation in the concentration.

21

This is due to fluid downstream of the ROI, which has lower fluorescein concentration prior to
reaching steady state, being drawn back into the ROI when valve Vin opens at t6 in Table 4.1.
This fluid is of course expelled from the ROI when DCA and DCB are actuated at t7 and therefore
replaced with higher concentration fluorescein mixture as the 1:1 mixer moves toward steady state
concentration output.
Figure 4.2(f-h) shows an alternate, much smaller (compare scale bars in Figs. 4.2(c) and
4.2(h)) 1:1 mixer module that uses pumps based on squeeze valves. The difference is that for this
design, we arranged the pumps such that they have individual outlet valves, and the pumps share
the same control lines. This reduces the number of phases required for a complete actuation cycle,
but also means the two fluids cannot be pumped separately. We found that the single stage mixers
with squeeze valves performed comparably to the membrane-valve based mixers. The 7-phase
valve timing logic sequence that we use to operate the squeeze valve-based 1:1 mixer is shown in
Table 4.2. Since the pumps share the same control lines, the number of phases is reduced by two
compared to the 1:1 mixer based on membrane valves.

4.2

Integrated 10-stage 2-fold serial dilution devices
Using 10 compact 1:1 mixer modules arranged in series, we designed a 10-stage serial

dilution module that provides simultaneous 2-fold dilution of a starting sample to ten outputs with
concentrations that cover 3 orders of magnitude. Each 1:1 mixer module comprises a single 2-fold
dilution stage in which its output is equally split between an output channel of the serial diluter
and the input to the next 2-fold dilution stage. Figure 4.3(a) shows a 3D CAD drawing of one of
our designs. The fluid to be serially diluted is introduced at the Fluid A input, and the diluent is
presented at the Fluid B input. Note that the Fluid B input is attached to a large manifold. The
Table 4.2: Timing sequence for squeeze valve-based mixer. With reference to Fig. 4.2 in the main
text, ”L”, ”C”, and ”R” are the left, center, and right squeeze valves, respectively. Red: valves
closed; green: valves open.
L
C
R
Vout

t0

t1

t2

t3

t4

t5

t6

•
•
•
•

•
•
•
•

•
•
•
•

•
•
•
•

•
•
•
•

•
•
•
•

•
•
•
•
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Figure 4.3: (a) CAD drawing and (b) microscope image of 10-stage 2-fold serial diluter. (c)
Normalized fluorescein concentration as a function of time for all 10 output channels (outputs 110) and the input concentration (output 0). (d) Steady state normalized fluorescein concentration
at each output channel for 3 repeated tests. (e) Microscope image of 10-stage 2-fold serial diluter
made with squeeze valve-based 1:1 mixer modules.

diluent inputs for each 2-fold dilution stage draw fluid from this manifold. The figure also shows
the 10 outlet channels from the 2-fold dilution stages, which are all connected to a waste outlet
since this design is intended only for proof-of-principle and measurement of the 10 simultaneously
generated output concentrations. The other cylindrical tubing connections in the CAD design are
for pneumatic control inputs for the various valves and DCs. The serial dilutor module contains
a total of 40 valves and 20 DCs. These are organized into 20 pumps, two for each 2-fold dilution
stage, and 10 diffusion channel outlet valves.
Figure 4.3(b) shows a microscope image of a fabricated device. The camera is at an angle
to the chip’s surface normal so that the narrow diffusion channels can be seen more clearly.
Figure 4.4(a) shows a chip with a 10-stage, 2-fold serial diluter (top of chip) and a singlestage 1:1 mixer (bottom of chip), while Fig. 4.4(b) shows a microscope photo of two identical
10-stage serial diluter mixers on one chip. In the case of both chips, the structures were fabricated
for characterization measurements. Around the border of each chip are cylindrical holes to which
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Figure 4.4: Serial dilution and mixer chips. (a) Photo of a chip with a 10 stage serial dilution mixer
and a single stage mixer. (b) Microscope photo of a chip with two 10 stage serial dilution mixers.
Both chips are 19.5 mm (length) × 12.2 mm (width) × 2.8 mm (height).

tubing is attached for fluid source and pneumatic control external connections. For purposes of
testing we typically fabricate two 10-stage serial diluters per chip; note that a single 10-stage serial
dilutor with its chip-to-world interconnects uses approximately 1/3 of the chip real estate, leaving
the rest of the chip available to place fluidic components to use the 10 serial diluter outputs in
parallel to ultimately permit conducting a complete dose-response assay on a single chip.
Figure 4.3(c) shows the normalized fluorescein concentration for each of the 10 serial diluter output channels as a function of time during startup of a 10-stage serial diluter. The initial
state of the serial diluter (t = 0) is diluent fluid in all the diluent pumps for all stages and outlet
channels, and undiluted fluorescein solution (denoted subsequently as 100% concentration) in all
the fluorescein solution pumps in each stage. This is because the experimental sequence was (1)
pump 100% fluorescein solution through the fluorescein pumps and into the output channels to
get a maximum fluorescence baseline, followed by (2) pump 100% diluent through the diluent
pumps and into the outlet channels to get a minimum fluorescence baseline, and then (3) normal
operation of the serial diluter in which all the pumps are used. The net result is that right after
starting step (3) at t = 0, there is a spike in fluorescence as the 100% fluorescein solution is cleared
from each stage’s fluorescein pump, followed by a decrease in fluorescence, and then a rise until
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Figure 4.5: Relative output concentrations of 3 different 10-stage serial diluter mixer.

steady state is reached. The important observation gained from Fig. 4.3(c) is that the fluorescein
concentrations reach steady state in all the output channels in less than 50 seconds of operation.
Figure 4.3(d) shows the steady state normalized fluorescein concentration in each of the output
channels where output 0 is the undiluted fluorescein solution. As expected, the output concentrations are linear on a log scale and cover three orders of magnitude of concentration. Figure 4.5
shows results of the same test using 3 different 10-stage serial diluter mixers.
We also created a 10-stage serial diluter as a proof-of-principle using the 1:1 mixer squeeze
valve module shown in Fig. 4.2(h). Our motivation was to demonstrate the miniaturization potential of components made with squeeze valves. A fabricated 10-stage serial diluter is shown in
Fig. 4.3(e). Note the extreme miniaturization where the x-y footprint of the serial diluter is only
2.2 mm × 1.1 mm. While the squeeze valve-based version of the serial diluter performed comparably to the larger membrane valve-based version, it took approximately 2.5 minutes to reach
steady state compared to the membrane-valve serial diluter because of the smaller amount of fluid
displaced by the squeeze valves compared to the volume of the output channels. We therefore
opted to use a membrane valve version for the serial diluter in our dose-response assay in the next
section because of the shorter time to achieve a steady state. Nonetheless, the preliminary proofof-principle device shown in Fig. 4.3(e) gives an indication of the largely unmined potential of 3D
printing for microfluidic device miniaturization and integration for common assays.
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Figure 4.6: (a) µCT image of 3D printed 5-stage diluter integrated with 3D printed cell plate.
(b) Fluorescence images of serially diluted fluorescein. The experiment was repeated three times
and all show similar results. (c) Cell treatment workflow. (d) Whole well images of differentially
treated A549 cells with propidium iodide as marker (red). Treatment fluid was 100 µg/mL digitonin and 2 µM propidium iodide in DMEM/F12 while the control fluid was 2 µM propidium
iodide in DMEM/F12. 100% ethanol was used as positive control for the whole experiment. (e)
Semi-log dose response-curve derived from the experiment. Responses were quantified through
measurement of propidium iodide area relative to the total cell area (DIC). Bounds were set at 0
µg/mL digitonin (0 response) and 100% ethanol (100% response). Values were derived from n=3
independent experiments.

4.3

Digitonin assay
As a proof-of-principle illustration of integrating a multi-stage serial diluter with a dose-

response assay, we designed a test system comprised of two 3D printed chips as illustrated in
Fig. 4.6(a) and Fig. 4.7. One chip Fig. 4.7(b) simultaneously generates 5 outputs with relative
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concentrations of 1/1, 1/2, 1/4, 1/8, and 0 from two input fluids, which we term the treatment fluid
(Fluid input 1) and the diluent fluid (Fluid input 2). A concentration of 0 represents an output with
only the diluent and serves as a negative control. The second chip is a cell plate that contains 5
microwells that are open on its upper surface as well as small waste channels. Each microwell
is 1.78 mm in diameter Fig. 4.7(a), holds 1 µL, and is surrounded by a microgasket as reported
in Ref. [6]. The two chips are clamped together with a custom holder to form a leak-tight seal
between the serial diluter chip and the cell plate chip. Each of the 5 fluid outputs of the serial
diluter chip is connected to a single cell plate microwell as indicated in Fig. 4.7(c). The serial
diluter chip is fabricated with our NPS-PEGDA resin [2], while the cell plate chip is fabricated
with our new biocompatible resin reported in Ref. [23].
To image the plates, micro-computer tomography (µCT) was used Fig. 4.7. An iodinepotassium iodide (I2/KI) solution was perfused into the fluidic channels which created high contrast compared to the bulk 3D printed polymer. For example, the pink channels in Fig. 4.6(a)
illustrate how the diluter outputs are routed to the microwells (yellow circles) on the cell plate
chip. In addition, fluorescein was used to confirm the diluter mechanism by presenting a fluorescein solution at the treatment input and cell culture media DMEM/F12 at the diluent input.
Figure 4.6(b) shows the expected diminishing fluorescence in the output channels for each serial
dilution stage and the lack of fluorescence for the negative control stage.
As a biological proof of concept using this 2-chip dose-response assay system, we show
selective permeabilization using digitonin, which is a steroidal saponin. The use of digitonin in selective permeabilization has been shown in chromaffin cells [24], astrocytes, [25]–[27] and cancer
cells such as A549 [28], [29] among others. The cell treatment workflow is shown in Fig. 4.6(c) in
which lung adenocarcinoma A549 cancer cells were seeded into the microwells of a cell plate chip
that had been surface modified with a 6-minute oxygen plasma treatment [23]. The cells were then
grown for 3 days until confluence, after which the cell plate chip was integrated with a serial diluter
chip. A cell impermeant nuclear stain, propidium iodide, was used as a marker of permeabilization. As shown in Fig. 4.6(d) and Fig. 4.8, we observed increasing nuclear stain with increasing
digitonin concentration. Data was collected and plotted on a semi-log dose-response curve using 0
µM digitonin as the baseline and 100% ethanol as the maximal response (Fig. 4.6(e)). We estimate
EC50 as 37.5 µM (24.0 µM to 57.2 µM, CI=95%, R2 =0.8386). Previously, various researchers re27

Figure 4.7: (a-c) Images of the iodine-perfused devices imaged using µCT scan. (a) The microfluidic cell plate treated with O2 plasma for cell adherence. This features cell culture microwells
(yellow circles, 1.78 mm in diameter) and output channels (red). (b) Diluter device with two fluid
inputs which feed the diluter mechanism. The diluted fluids are pumped to the sink, which contains
5 outlet channels. (c) Integrated 5-stage diluter showing the microfluidic cell plate (brown) fitting
onto the diluter device (grey). In this paper, the fluid inputs were perfused with control (diluent)
and treatment fluids. These fluids pass through the diluter mechanism which pumps the diluted
fluids to the sink which directly fills the cell culture wells with the appropriate dilutions of the
treatment, which in this paper, is digitonin. (d) The same device was imaged through transmitted
light microscopy with image stitching. Zoomed image shows the details of the diluter mechanism
piping system.
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Figure 4.8: Representative images for the digitonin-induced permeabilization of A549 cells. The
top row shows the dilution profile by the device. The middle row shows the virtually equal cell
coverage between cell culture wells as imaged through DIC. The bottom row shows the propidium
iodide signal. Each microwell has a diameter of 1.78 mm.

ported a range of digitonin concentrations used in cell membrane permeabilization experiments.
Experiments on bovine chromaffin cells reported the use of 30 µM digitonin to achieve 90% cell
permeabilization. [30] Moreover, in astrocytes [25]–[27], 20-30 µM digitonin was used while 2040 µM digitonin was used in A549 cells [28], [29] to achieve at least 75% plasma membrane
permeabilization. Though, to our reading, definitive EC50 derivation for digitonin-based permeabilization in A549 has not yet been established. Alternatively, an EC50 value of 65.79 µM for
digitonin has been shown in CHO cells using an Aequorin reporter assay. [31]
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CHAPTER 5.

5.1

METHODS

Materials
For 3D printing we use a custom photopolymerizable resin which consists of poly(ethylene

glycol) diacrylate (PEGDA, MW258) with a 1% (w/w) phenylbis(2,4,6-trimethylbenzoyl)phosphine
oxide (Irgacure 819) photoinitiator and a 2% (w/w) 2-nitrophenyl phenyl sulfide (NPS) UV absorber, details of which are provided in Refs. [2], [6], [7].
Uranine powder (40%) was procured from Fischer Science and sodium hydroxide pellets
were supplied by Macron Fine Chemicals.

5.2

3D printing and sample preparation
The 3D printer used in this paper is described in Ref. [17] as the Generation 2 3D printer

and is based on the custom 3D printer reported in Ref. [2]. It has a 385 nm LED light source
and a pixel pitch of 7.6 µm in the projected image plane. For 3D printing substrates, we use 25
mm square silanized glass slides. Slides are first rinsed with acetone and isopropyl alcohol (IPA),
and then immersed in toluene mixed with 10% 3-(trimethoxysilyl)propyl methacrylate for 2 hours.
After silanization, we store the glass slides in fresh toluene inside a closed container until use,
which ranges from under an hour to several weeks. Unless otherwise noted, all 3D prints reported
in this paper are fabricated with a layer thickness of 10 µm and an exposure time of 900 ms. The
image plane irradiance is 21.2 mW·cm−2 with an LED source spectrum as reported in Ref. [2].

5.3

Pump measurements
We followed the video analysis method detailed in Ref. [7] to measure pump volumetric

flow rate as a function of phase time. We recorded video at 240 frames per second using a cell
phone camera attached to a microscope while pumping of a dye fluid through an initially empty
30

microfluidic channel with known dimensions. This allowed us to track the fluid meniscus frameby-frame with a custom Python script to determine the volumetric flow rate. The inlet fluid and the
outlet of the pump were kept at the same height as the pump to permit the determination of fluid
flow for zero back pressure.

5.4

Mixer measurements
We also followed a video analysis method to measure the effectiveness of diffusion channel

mixing based on an analysis of the fluorescence standard deviation (see Ref. [7] for details). We
used 100 µM fluorescein in 0.1M NaOH and 0.1M NaOH as fluid inputs A and B, respectively.
A phase interval of 50 ms (450 ms per full mixer cycle) was sufficient to completely mix the
fluorescein solution. In addition, pressures of 25 PSI and 10 PSI were used to actuate valves
and DCs, respectively. An Olympus IX73 fluorescence microscope and ORCA-Flash 4.0 camera
(Hamamatsu) were used for fluorescein fluorescence measurements.

5.5

Serial dilutor measurements
Serial diluter characterization was also done with 100 µM fluorescein in 0.1M NaOH dilu-

ent and 0.1M NaOH as fluid inputs A and B, respectively. Fluorescence in the serial diluter output
channels is normalized to that of the undiluted sample fluid and converted to percent. Microscopy
at non-normal incidence was performed with a Keyence VHX-970 Digital Microscope.

5.6
5.6.1

Dose response assay measurements
O2 plasma treatment
Cell plates were exposed to O2 plasma for 6 minutes using a parallel-plate plasma etcher

(Technics PlanarEtch II) at 200 W with 10 sccm O2 . Cell plates were then cleaned with 100%
isopropyl alcohol (IPA) for 1 hr and dried overnight at 55◦ C in an oven.
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5.6.2

Cell seeding and treatment
A549 adenocarcinoma cells (ATCC CCL-185) were maintained in DMEM/F12 media (Corn-

ing, 10-092-CV) supplemented with 10% FBS (VWR, 89510-186) and 1X Antibiotic-Antimycotic
(Caisson Labs, 89510-186). Cells were detached from the cell plates using 0.25% trypsin-EDTA
(Gibco, 25200-072). Approximately 1.65x104 cells were seeded in each microwell. The cells were
maintained on the cell plate for 2 or 3 days prior treatment.
3D printed chips with the 5-stage serial diluter were primed with TWEEN-80 (0.05% in
deionized water) for 10 minutes to eliminate bubbles inside the device. Then both Fluid 1 (diluent, 3 µg/mL propidium iodide in DMEM/F12) and Fluid 2 (200 µg/mL digitonin + 3 µg/mL
propidium iodide in DMEM/F12) were introduced in the device using two syringe pumps at 40
µL/min (Fluid 1) and 10 µL/min (Fluid 2) while agitating the inputs until there were no bubbles
inside the chip. The syringe pump was then disconnected and the serial diluter was turned on and
operated with a phase interval of 50 ms. After equilibration, the chip with cell-seeded wells was
mounted and clamped on top of the serial diluter chip. The cells were treated for approximately
20 minutes, following which the cell plate was separated from the serial diluter. The cell plate was
then immediately fixed using 1% paraformaldehyde in PBS (Thermo Fischer Scientific, 256956)
for 15 minutes at 37°C with mild agitation then incubated for 5 minutes with a PBS wash three
times. The cell plate was then imaged using an Olympus IX73 microscope and ORCA-Flash 4.0
camera (Hamamatsu). A separate cell plate was used for the ethanol control. Each cell plate was
soaked in 3 µg/mL propidium iodide diluted in 100% ethanol for 20 minutes at room temperature
followed by an incubation of 5 minutes with a PBS wash three times.

5.6.3

Image processing and analysis
Fluorescence images were processed using Fiji (ImageJ 1.52p, National Institutes of Health

USA) using the background removal function. Intensity signals were quantified as area of positive
cells through Fiji thresholding and area measurement. Visible light images were stitched using
Adobe Photoshop CC 2018 (Adobe Systems Incorporated). Data were processed using Graphpad
Prism Version 8.4.2 (Graphpad Software, LLC). Limits were set to the 100% ethanol as the 100%
permeabilization response and 0µg/mL digitonin as the baseline response.
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5.6.4

µCT scans and light microscopy of the chips
Microchip wells and channels were filled with stabilized gram iodine (Difco, Detroit, MI)

to provide contrast inside fluid channels. Chips were then scanned using a QuantumGX2 µCT
scanner (PerkinElmer, Waltham, MA) at the following settings: 4 min High resolution, Al 0.5 mm
+ Cu 0.06 mm filter, 36 mm FOV, 90 kV, 88 µA. After initial scan images were reconstructed to a
final voxel size of 25 µm and 9 µm. 3D images were then reconstructed as a Maximum Intensity
Projection using Caliper Analyze 12.0 (AnalyzeDirect, Inc., Overland Park, KS). False coloring
was achieved using Adobe Photoshop CC 2018. Photomicrographs of the chips are taken using a
Canon EOS Rebel SL2 camera mounted on an Olympus BX51 microscope with UPlanFL N 4x
objective. Image stitching basic light correction was done in Adobe Photoshop CC 2018.
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CHAPTER 6.

SUMMARY AND FUTURE RESEARCH

We show that the flexibility to arbitrarily mix and match layer thicknesses and pixel doses
afforded by our custom high-resolution 3D printer allows us to reduce the diameter of 3D printed
membrane valves by a factor of 6.5 from our previously published result of 300 µm [6] to 46
microns. This in turn reduces the volume occupied by a membrane valve by ∼40×. We also show
the development of a new kind of 3D printed valve, a squeeze valve, in which the active area is
reduced still further to only 15 µm × 15 µm. Both classes of miniaturized valves can be combined
to form pumps, which are useful for a variety of applications. We have shown that two pumps
pushing different fluids into a high-aspect ratio channel allows the fluids to mix in a 1:1 ratio,
forming a 1:1 mixer. These 1:1 mixers based on membrane valve pumps can be combined to form a
10-stage serial diluter that reaches steady state in less than one minute and simultaneously produces
serial dilution concentrations that span 3 orders of magnitude. We also showed a substantially
smaller 10-stage serial diluter based on squeeze valve pumps.
To demonstrate how a microfluidic serial diluter can be used to perform a dose-response
assay, we developed a device that concurrently generates 5 fluid concentrations that are pumped
into 5 microwells suitable for cell culture. We used this system in collaboration with the Christensen and Van Ry groups at BYU to demonstrate a proof-of-principle cell permeabilization assay
by measuring the dose-dependent uptake of the fluorophore propidium iodide after treatment of
different cell populations with 5 different concentrations of digitonin. Our demonstration of highly
miniaturized 3D printed microfluidic valves, pumps, and integrated on-chip serial diluters opens
the opportunity for applications in drug research, precision medicine, and beyond.
Finally, some of the research ideas concerning the serial dilution mixer that in my view
should be pursued next are the following:
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• Explore how effective the high aspect ratio channel for mixing two solutions in different
proportions that were introduced by pumps with different sizes. This would allow to create
a serial dilution mixer in which each stage has a mixing ratio different than 1:1.
• Fully characterize the valves and pumps for multiple parameters in terms of printing yield,
closing pressure, maximum allowable pressure, etc. This will allow to increase the yield of
the serial dilution mixer chips.
• Move the world-to-chip connections to an interface chip as done in Reference [6]. This will
decrease the time required to print a new serial dilution chip by reducing the number of
layers of the whole chip.
• Create a software program that automatically generates the best possible layer thicknesses
and pixel doses for every single layer based on the mathematical foundations described in
References [2], [4] such that it would produced the optimal parameters for fabricating the
serial diluter void features.

35

REFERENCES
[1] C. I. Rogers, K. Qaderi, A. T. Woolley, and G. P. Nordin, “3d printed microfluidic devices
with integrated valves,” Biomicrofluidics, vol. 9, no. 1, pp. 1–9, 2015. v, 3, 4, 7
[2] H. Gong, B. P. Bickham, A. T. Woolley, and G. P. Nordin, “Custom 3d printer and resin for
18 µm× 20 µm microfluidic flow channels,” Lab on a Chip, vol. 17, no. 17, pp. 2899–2909,
2017. v, 4, 5, 7, 8, 9, 11, 27, 30, 35
[3] M. J. Beauchamp, G. P. Nordin, and A. T. Woolley, “Moving from millifluidic to truly microfluidic sub-100-µm cross-section 3d printed devices,” Analytical and Bioanalytical Chemistry, pp. 1–9, 2017. 3
[4] H. Gong, M. Beauchamp, S. Perry, A. T. Woolley, and G. P. Nordin, “Optical approach to
resin formulation for 3d printed microfluidics,” RSC Advances, vol. 5, no. 129, pp. 106 621–
106 632, 2015. 4, 9, 11, 35
[5] H. Gong, A. T. Woolley, and G. P. Nordin, “High density 3d printed microfluidic valves,
pumps, and multiplexers,” Lab on a Chip, vol. 16, no. 13, pp. 2450–2458, 2016. 4, 7, 15, 16,
19
[6] H. Gong, A. Woolley, and G. Nordin, “3d printed high density, reversible, chip-to-chip microfluidic interconnects,” Lab on a Chip, vol. 18, no. 4, pp. 639–647, 2018. 5, 7, 8, 11, 27,
30, 34, 35
[7] H. Gong, A. T. Woolley, and G. P. Nordin, “3d printed selectable dilution mixer pumps,”
Biomicrofluidics, vol. 13, no. 1, p. 014106, jan 2019. 5, 15, 16, 21, 30, 31
[8] P. Juelg, M. Specht, E. Kipf, M. Lehnert, C. Eckert, M. Keller, T. Hutzenlaub, F. von Stetten, R. Zengerle, and N. Paust, “Automated serial dilutions for high-dynamic-range assays
enabled by fill-level-coupled valving in centrifugal microfluidics,” Lab Chip, vol. 19, no. 13,
pp. 2205–2219, 2019. 6
[9] S. K. W. Dertinger, D. T. Chiu, N. L. Jeon, and G. M. Whitesides, “Generation of gradients
having complex shapes using microfluidic networks,” Anal. Chem., vol. 73, no. 6, pp. 1240–
1246, 2001. 6
[10] C. Kim, K. Lee, J. H. Kim, K. S. Shin, K. J. Lee, T. S. Kim, and J. Y. Kang, “A serial dilution
microfluidic device using a ladder network generating logarithmic or linear concentrations,”
Lab Chip, vol. 8, no. 3, pp. 473–479, 2008. 6
[11] K. Hattori, S. Sugiura, and T. Kanamori, “Generation of arbitrary monotonic concentration
profiles by a serial dilution microfluidic network composed of microchannels with a high
fluidic-resistance ratio,” Lab Chip, vol. 9, no. 12, pp. 1763–1772, 2009. 6
36

[12] S. Sugiura, K. Hattori, and T. Kanamori, “Microfluidic serial dilution cell-based assay for
analyzing drug dose response over a wide concentration range,” Anal. Chem., vol. 82, no. 19,
pp. 8278–8282, 2010. 6
[13] M. C. Yu, X. Y. Chen, H. J. Qu, L. Ma, L. Xu, W. Y. Lv, H. Wang, R. F. Ismagilov, M. Li, and
F. Shen, “Multistep slipchip for the generation of serial dilution nanoliter arrays and hepatitis
b viral load quantification by digital loop mediated isothermal amplification,” Anal. Chem.,
vol. 91, no. 14, pp. 8751–8755, 2019. 6
[14] M. A. Unger, H.-P. Chou, T. Thorsen, A. Scherer, and S. R. Quake, “Monolithic microfabricated valves and pumps by multilayer soft lithography,” Science, vol. 288, no. 5463, pp.
113–116, 2000. 7
[15] A. K. Au, N. Bhattacharjee, L. F. Horowitz, T. C. Chang, and A. Folch, “3d-printed microfluidic automation,” Lab on a Chip, vol. 15, no. 8, pp. 1934–1941, 2015. 7
[16] A. P. Kuo, N. Bhattacharjee, Y.-S. Lee, K. Castro, Y. T. Kim, and A. Folch, “High-precision
stereolithography of biomicrofluidic devices,” Advanced Materials Technologies, vol. 4,
no. 6, p. 1800395, jan 2019. 7
[17] G. P. Nordin, H. Gong, M. Viglione, K. Hooper, and A. T. Woolley, “3D printing for lab-on-achip devices with 20 um channels,” in Emerging Digital Micromirror Device Based Systems
and Applications XI, M. R. Douglass, J. Ehmke, and B. L. Lee, Eds., vol. 10932, International
Society for Optics and Photonics. SPIE, 2019, pp. 29 – 36. 9, 30
[18] J. Francis, I. Stamper, J. Heikenfeld, and E. F. Gomez, “Digital nanoliter to milliliter flow rate
sensor with in vivo demonstration for continuous sweat rate measurement.” Lab on a chip,
vol. 19, pp. 178–185, Dec 2018. 16
[19] C.-Y. Lee, C.-L. Chang, Y.-N. Wang, and L.-M. Fu, “Microfluidic mixing: a review.” International journal of molecular sciences, vol. 12, pp. 3263–87, 2011. 17
[20] G. Cai, L. Xue, H. Zhang, and J. Lin, “A review on micromixers,” Micromachines, vol. 8,
Sep 2017. 17
[21] Y. K. Suh and S. Kang, “A review on mixing in microfluidics,” Micromachines, vol. 1, no. 3,
pp. 82–111, sep 2010. 17
[22] S. T. Nguyen, Nam-Trung; Wereley, Fundamentals and Applications of Microfluidics.
Artech House, 2002. 17
[23] C. Warr, J. C. Valdoz, B. P. Bickham, C. J. Knight, N. A. Franks, N. Chartrand, P. M. Van Ry,
K. A. Christensen, G. P. Nordin, and A. D. Cook, “Biocompatible pegda resin for 3d printing,”
ACS Applied Bio Materials, vol. 3, no. 4, pp. 2239–2244, 2020. 27
[24] L. S. Kao, “Calcium homeostasis in digitonin-permeabilized bovine chromaffin cells.” Journal of neurochemistry, vol. 51, pp. 221–7, Jul 1988. 27
[25] F. Tramontina, J. Karl, C. Gottfried, A. Mendez, D. Gonçalves, L. V. Portela, and C. A.
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